PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sphere of biopharmaceuticals, featuring promising advancements across different healthcare and industrial programs. With its structural similarity to The natural way derived human serum albumin, OsrHSA provides a safer, far more dependable choice for therapeutic